drugset / Trial / NCT00437125
Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease
NaSingle-groupOpen-labelTreatment
Summary
This study aims to assess the tolerability of duloxetine, 60mg once daily, in open label fashion, in depressed patients with Parkinson's disease during 12 weeks treatment.
Timeline
- Start
- 2007-03
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 60 mg | Oral |